IHEvsJDOC
iShares U.S. Pharmaceuticals ETF against JPMorgan Healthcare Leaders ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IHE | JDOC | |
|---|---|---|
| Expense ratio | 0.40% | 0.65% |
| Assets | $1.6B | $8911.98T |
| Net flow, 1 month | +$25M | — |
| Net flow, 1 year | +$795M | −$25K |
| Return, YTD | +16.3% | +2.9% |
| Return, 1 year | +30.5% | +9.4% |
| Avg daily volume | 177K | 229 |
| Holdings | 38 | 67 |
| Listed | May 1, 2006 | Oct 31, 2023 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS